OTCMKTS:ZRSEF DocMorris (ZRSEF) Stock Price, News & Analysis $7.45 0.00 (0.00%) As of 09/25/2026 Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartNews and Trends About DocMorris Stock (OTCMKTS:ZRSEF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get DocMorris alerts:Sign Up Key Stats Today's Range$7.45▼$7.4550-Day Range$7.45▼$7.4552-Week Range$7.45▼$42.50VolumeN/AAverage Volume350 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingModerate Buy Company Overview DocMorris AG, formerly known as Zur Rose Group AG, is a Swiss healthcare company that operates primarily as an online pharmacy and digital health platform. The company offers prescription and nonprescription medicines, health and wellness products, beauty items, nutritional supplements and related pharmacy services through its digital channels. DocMorris serves customers and healthcare professionals primarily in Germany, where its platform supports the ordering and delivery of medicines. Its services include electronic prescription fulfillment, medication delivery, digital health tools and online access to pharmacy information and advice. The company has also historically operated pharmacy and healthcare businesses in Switzerland and other European markets. The business was established in Switzerland in the 1990s and adopted the DocMorris name as part of its broader repositioning as a digital healthcare platform. The company is headquartered in Frauenfeld, Switzerland, and is led by Chief Executive Officer Walter Hess.AI Generated. May Contain Errors. Read More Receive ZRSEF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for DocMorris and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ZRSEF Stock News HeadlinesDocMorris Secures Oversubscribed CHF 96.8 Million Convertible Bond on Improved TermsSeptember 11, 2026 | tipranks.comDocMorris AG Earnings Call Signals AI‑Driven TurnaroundAugust 21, 2026 | tipranks.comA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.September 28 at 1:00 AM | Porter & Company (Ad)DocMorris AG (ZRSEF) Q2 2026 Earnings Call TranscriptAugust 21, 2026 | seekingalpha.comDocMorris (DOCM) Gets a Buy from JefferiesJune 5, 2026 | theglobeandmail.comDocMorris AG (ZRSEF) Q1 2026 Earnings Call TranscriptApril 17, 2026 | seekingalpha.comDOCMORRIS AGMarch 27, 2026 | finanznachrichten.deDocMorris AG Charts Costly Yet Credible TurnaroundMarch 26, 2026 | tipranks.comSee More Headlines ZRSEF Stock Analysis - Frequently Asked Questions How have ZRSEF shares performed this year? DocMorris' stock was trading at $7.4540 on January 1st, 2026. Since then, ZRSEF shares have increased by 0.0% and is now trading at $7.4540. How do I buy shares of DocMorris? Shares of ZRSEF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorConsumer Staples Industry Consumer Staples Distribution & Retail Sub-IndustryN/A Current SymbolOTCMKTS:ZRSEF CIKN/A Webwww.zurrosegroup.com Phone(152) 724-0020FaxN/AEmployees1,453Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report This page (OTCMKTS:ZRSEF) was last updated on 9/28/2026 by MarketBeat.com Staff. From Our PartnersMeet the drone firm selected for the Pentagon's counter-drone programOne Nasdaq-listed drone company already supplies the US Army, Air Force, and Navy with mission-ready drone sys...Tomorrow Investor | SponsoredA Little Known Explorer Sits Near Major Gold DepositsBarrick Mining has spent decades building one of the world's great gold districts in Nevada, anchored by Fourm...Wall Street Logic | SponsoredUnder $5, Is This Nasdaq Early to America's Next Defense Boom?Small drones costing hundreds of dollars can now rival tanks and equipment worth millions, a shift Ukraine has...i2i Marketing Group, LLC | SponsoredThe Department of War is on a gold mine's filingsOn May 21, 2026, a federal bank board unanimously approved a nearly $3 billion loan to build a gold mine on Am...Behind the Markets | SponsoredBuffett's Final Warning: "The Dollar Is Going to Hell"On May 3rd, 2025, Warren Buffett looked at his shareholders for the last time and said: "The dollar is going t...Decentralized Masters | SponsoredShould You Convert a Traditional IRA to a Roth After 60?Considering a Roth conversion after 60? The upside includes no income limits on conversions, potential tax-fre...SmartAsset | SponsoredThis AI Stock Reminds One Analyst of Early NvidiaJeff Brown picked Nvidia in 2016, before shares surged 37,800 percent. Now he's identified another AI company ...Brownstone Research | SponsoredA bill in Congress would require the Treasury to reprice America's gold. Here is what it means for your 401k.The US government still values its gold reserves at $42 an ounce, a price set by Congress back in 1973 and nev...Monetary Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DocMorris AG Please log in to your account or sign up in order to add this asset to your watchlist. Share DocMorris With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.